Synergic Effect of Trimebutine Combined with Mosapride on Gastrointestinal Dysfunction and Visceral Pain Induced in Stress Models |
Park, Young-Joon
(Research Center, Samil Pharmaceutical Co. Ltd.)
Park, Yong-Sul (College of Medicine, Chung-Ang Universty) Chung, Zoo-Chul (College of Medicine, Chung-Ang Universty) Nam, Yun-Sung (College of Medicine, Chung-Ang Universty) Chung, Yoon-Hee (College of Medicine, Chung-Ang Universty) Cho, Kwan-Hyung (Research Center, Samil Pharmaceutical Co. Ltd.) Choi, Sung-Up (Research Center, Samil Pharmaceutical Co. Ltd.) Sohn, Uy-Dong (College of Pharmacy, Chung-Ang University) Park, Eon-Sub (College of Medicine, Chung-Ang Universty) Je, Hyun-Dong (Department of Pharmacology, College of Pharmacy, Catholic University of Daegu) Lee, Choong-Ho (Division of Gastroenterology and Hepatology, School of Medicine, Stanford University) Lee, Moo-Yeol (College of Medicine, Chung-Ang Universty) Jeong, Ji-Hoon (College of Medicine, Chung-Ang Universty) |
1 | Wingate, D., Hongo, M., Kellow, J., Lindberg, G. and Smout, A. (2002) Disorders of gastrointestinal motility: towards a new classification. J. Gastroenterol. Hepatol. 17(Suppl), S1-14. DOI |
2 | Yoshida, N., Ito, T., Karasawa, T. and Itoh, Z. (1991) AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs. J. Pharmacol. Exp. Ther. 257, 781-787. |
3 | Yoshida, N., Omoya, H., Kato, S. and Ito, T. (1993) Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals. Arzneimittelforschung 43, 1078-1083. |
4 | Zenilman, M. E. (1993) Origin and control of gastrointestinal motility. Surg. Clin. North. Am. 73, 1081-1099. |
5 | Zhang, H. Q., Zhou, C. H. and Wu, Y. Q. (2005) Effect of emodin on small intestinal peristalsis of mice and relevant mechanism. World J. Gastroenterol. 11, 3147-3150. DOI |
6 | Sakurai-Yamashita, Y., Takada, K., Takemura, K., Yamashita, K., Enjoji, A., Kanematsu, T. and Taniyama, K. (1999) Ability of mosapride to bind to 5-HT4 receptor in the human stomach. Jpn. J. Pharmacol. 79, 493-496. DOI |
7 | Shimada, T., Kurachi, Y., Terano, A., Hamada, E. and Sugimoto, T. (1990) Trimebutine maleate has inhibitory effects on the voltage-dependent Ca2+ inward current and other membrane currents in intestinal smooth muscle cells. Gastroenterol. Jpn. 25, 175-179. |
8 | Takenaga, H., Magaribuchi, T. and Tamaki, H. (1984b) Effects of trimebutine maleate (TM-906) on the spontaneous contraction of isolated guinea pig colon. Jpn. J. Pharmacol. 34, 177-181. DOI |
9 | Takagi, K. and Okabe, S. (1968) The effects of drugs on the production and recovery processes of the stress ulcer. Jpn. J. Pharmacol. 18, 9-18. DOI |
10 | Takenaga, H., Magaribuchi, T. and Tamaki, H. (1984a) Effects of trimebutine maleate (TM-906) on the smooth muscles of isolated guinea pig gallbladder. Jpn. J. Pharmacol. 35, 439-443. DOI |
11 | Takenaga, H., Magaribuchi, T. and Tamaki, H. (1986) Effects of trimebutine maleate (TM-906) on the spontaneous contraction of isolated duodenum and ileum in both guinea pigs and rabbits. Jpn. J. Pharmacol. 40, 13-20. DOI |
12 | Tanaka, M. (1998) Gastric ulcer, motility, and trimebutine. J. Gastroenterol. 33, 916-917. DOI |
13 | Uchiyama, M., Iwafuchi, M., Yagi, M., Iinuma, Y., Kanada, S., Ohtaki, M. and Homma, S. (2000) Effects of trimebutine on intestinal motility after massive small bowel resection. J. Smooth. Muscle. Res. 36, 117-126. DOI |
14 | Washabau, R. J. (2003) Gastrointestinal motility disorders and gastrointestinal prokinetic therapy. Vet. Clin. North Am. Small Anim. Pract. 33, 1007-1028, vi. DOI |
15 | Kii, Y., Nakatsuji, K., Nose, I., Yabuuchi, M., Mizuki, Y. and Ito, T. (2001) Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats. Pharmacol. Toxicol. 89, 96-103. DOI |
16 | Koop, H., Monnikes, H., Koop, I., Dionysius, J., Schwarz, C. and Arnold, R. (1986) Effect of the prokinetic drug cisapride on gastrointestinal hormone release. Scand. J. Gastroenterol. 21, 907-913. DOI |
17 | Mine, Y., Yoshikawa, T., Oku, S., Nagai, R., Yoshida, N. and Hosoki, K. (1997) Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J. Pharmacol. Exp. Ther. 283, 1000-1008. |
18 | Kountouras, J., Chatzopoulos, D., Zavos, C., Boura, P., Venizelos, J. and Kalis, A. (2002) Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome. Hepatogastroenterology 49, 193-197. |
19 | Luttecke, K. (1978) A trial of trimebutine in spastic colon. J. Int. Med. Res. 6, 86-88. DOI |
20 | Matsue, T., Yamato, S. and Umeda, N. (1990) Mechanism of action of trimebutine maleate on gastro-colic reflex in patients with irritable bowel syndrome. Nippon Heikatsukin Gakkai Zasshi 26, 89-92. |
21 | Nosaka, K., Takenaga, H., Magaribuchi, T. and Tamaki, H. (1984) Effects of trimebutine maleate (TM-906) on the gastrointestinal motility in anesthetized dogs. Nippon Heikatsukin Gakkai Zasshi 20, 407-412. DOI ScienceOn |
22 | Odaka, T., Suzuki, T., Seza, A., Yamaguchi, T. and Saisho, H. (2006) Serotonin 5- HT4 receptor agonist (mosapride citrate). Nippon Rinsho 64, 1491-1494. |
23 | Reynolds, J. C. and Putnam, P. E. (1992) Prokinetic agents. Gastroenterol. Clin. North Am. 21, 567-596. |
24 | Roman, F. J., Lanet, S., Hamon, J., Brunelle, G., Maurin, A., Champeroux, P., Richard, S., Alessandri, N. and Gola, M. (1999) Pharmacological properties of trimebutine and N-monodesmethyltrimebutine. J. Pharmacol. Exp. Ther. 289, 1391-1397. |
25 | Chicella, M. F., Batres, L. A., Heesters, M. S. and Dice, J. E. (2005) Prokinetic drug therapy in children: a review of current options. Ann. Pharmacother. 39, 706-711. DOI |
26 | Delvaux, M. and Wingate, D. (1997) Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results. J. Int. Med. Res. 25, 225-246. |
27 | Chua, A. S., Bekkering, M., Rovati, L. C. and Keeling, P. W. (1994) Clinical efficacy and prokinetic effect of the CCK-A antagonist loxiglumide in nonulcer dyspepsia. Ann. N. Y. Acad. Sci. 713, 451-453. DOI |
28 | Curran, M. P. and Robinson, D. M. (2008) Mosapride in gastrointestinal disorders. Drugs 68, 981-991. DOI |
29 | Delco, M. L., Nieto, J. E., Craigmill, A. L., Stanley, S. D. and Snyder, J. R. (2007) Pharmacokinetics and in vitro effects of tegaserod, a serotonin 5-hydroxytryptamine 4 (5-HT4) receptor agonist with prokinetic activity in horses. Vet. Ther. 8, 77-87. |
30 | Dubinsky, B., Gebre-Mariam, S., Capetola, R. J. and Rosenthale, M. E. (1987) The antialgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia. Agents Actions 20, 50-60. DOI |
31 | Greenwood, B. and Davison, J. S. (1987) The relationship between gastrointestinal motility and secretion. Am. J. Physiol. 252, G1-7. |
32 | Hawkyard, C. V. and Koerner, R. J. (2007) The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. J. Antimicrob. Chemother. 59, 347-358. DOI |
33 | Holzer, P. (2004) Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neurosci. Lett. 361, 192-195. DOI |
34 | Boyle, G., Mounsey, A. and Crowell, K. (2009) Clinical inquiries: what is the role of prokinetic agents for constipation? J. Fam. Pract. 58, 220d-220f. |